Since DCLK1-L and DCLK1-S isoforms are generated respectively from the alternative usage of α and β promoters (Fig. 1B), we evaluated changes in DCLK1 alternative-promoter choice during ccRCC tumorigenesis. The gene discussed is DCLK1; the disease is nonpapillary renal cell carcinoma.